Published on 2 Apr 2022 on Bloomberg
Lexicon Says Drug Reduced Major Cardiovascular Events in Trial
Lexicon Pharmaceuticals Inc. said new analysis of a clinical trial showed sotagliflozin...
NASDAQ.LXRX price evolution
Want to become a better investor?
Start tracking your investments with Statfolio
Sign up for free